Duquesne Family Office’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-74,400
| Closed | -$1.78M | – | 42 |
|
|
2023
Q2 | $1.78M | Hold |
74,400
| – | – | 0.06% | 49 |
|
|
2023
Q1 | $1.4M | Hold |
74,400
| – | – | 0.06% | 45 |
|
|
2022
Q4 | $1.18M | Hold |
74,400
| – | – | 0.06% | 53 |
|
|
2022
Q3 | $1.22M | Hold |
74,400
| – | – | 0.07% | 58 |
|
|
2022
Q2 | $1.05M | Hold |
74,400
| – | – | 0.08% | 39 |
|
|
2022
Q1 | $1.8M | Hold |
74,400
| – | – | 0.08% | 47 |
|
|
2021
Q4 | $1.74M | Hold |
74,400
| – | – | 0.06% | 46 |
|
|
2021
Q3 | $1.24M | Hold |
74,400
| – | – | 0.04% | 46 |
|
|
2021
Q2 | $1.82M | Buy |
+74,400
| New | +$1.82M | 0.05% | 50 |
|